Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by everswannon Feb 28, 2008 5:09pm
104 Views
Post# 14567871

RE: Congrats everswann

RE: Congrats everswannI like the molecule, I think there is a fundamental shift in prescription drugs (exponential off-label usage). I think TH will be one of the major benefiter but right now it's technical. No one could have predicted that management would screw up. No one. Morons like houplamoron claim to smart and savvy but there are not. There just lucky. Now, TH broke resistance at 8,50$. I don't see it floating up in a context where there is a vacuum of news and hype. If you go long, you will be rewarded. you need to patient and endure the pain. I am dodging the capitulation wave and moving back on floor level. If they get a bid or rumor comes stirring back, i'll be back. I am just being rational and I am just managing my portefolio. I shifted money into other stock and I already recoup my losses from TH. But for some reason this post is going to insult people again ... TH is down because people are stupid enough to sell it. People like houplamoron.
Bullboard Posts